Breaking News - The Fly

Open Search

IFRX

InflaRx

$

()

InflaRx announces INF904 development plans

IFRX

3/21/2024 - 07:08am

InflaRx sees cash runway into at least 2026

IFRX

3/21/2024 - 07:06am

InflaRx reports 2023 EPS (EUR 0.78) vs. (EUR 0.67) last year

IFRX

3/21/2024 - 07:05am

InflaRx appoints Medina as Head of Investor Relations

IFRX

2/22/2024 - 07:46am

InflaRx price target lowered by $1 at H.C. Wainwright, here's why

IFRX

1/25/2024 - 11:14am

InflaRx announces initiation of its commitment program for GOHIBIC

IFRX

1/25/2024 - 07:32am

InflaRx announces 'positive' topline results from MAD Phase I study of INF904

IFRX

1/4/2024 - 07:02am

Biotech Alert: Searches spiking for these stocks today

CYTO , IFRX , AUTL

…

11/6/2023 - 11:19am

InflaRx announces first patient dosed in Phase III trial

IFRX

11/6/2023 - 07:47am

InflaRx reports Q3 EPS (EUR 0.13) vs (EUR 0.18) last year

IFRX

11/1/2023 - 07:35am

InflaRx announces results from its SAD Phase I study with INF904

IFRX

9/11/2023 - 07:15am

InflaRx MAA for vilobelimab under review by EMA

IFRX

8/30/2023 - 07:34am

InflaRx expects cash to fund operations at least into 2026

IFRX

8/10/2023 - 07:35am

InflaRx reports Q2 EPS (14c), consensus (34c)

IFRX

8/10/2023 - 07:35am

InflaRx files $250M mixed securities shelf

IFRX

6/30/2023 - 16:08pm